Inflammatory Bowel Disease - The latest progress of biologics drug development and market trends

Are you looking to gain in-depth knowledge of the latest biologics advancements and market trends in Inflammatory Bowel Disease (IBD)? Discover how innovative modalities, like cytokines inhibitors and anti-integrin antibodies, are revolutionizing IBD therapies. Learn about the latest advances, drug milestones, and future opportunities in this thriving field. In our webinar, we take a 360-degree view of the IBD research and discuss strategies for addressing challenges during the IBD relevant antibody development.​​​​​​​

Guest speaker

Dr. Fengfeng Wang

Product Manager of ACROBiosystems

Topic:

Inflammatory Bowel Disease: the latest progress of biologics Drug development and Market Trends

Organizers

ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. We supply life science tools designed to be used in discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, we deliver solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. We empower scientists and engineers dedicated towards innovation to simplify and accelerate the development of new, better, and more affordable medicine.